ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $65,961, the best ever quarter in terms of revenues in corporate history and an increase of 35% over the $49,026 recorded in the third quarter, fiscal year 2006. Net income after taxes in Q3FY07 was $4,189 resulting in fully diluted earnings per share (EPS) of $.30, up 14% from the prior fiscal year third quarter net income after taxes of $3,679 and EPS of $.27. Gross profits on revenues for the current quarter were $33,494 resulting in a margin for gross profit on revenues of 51%, versus the $24,343 reported for the prior fiscal year third quarter, which was 50%. Revenue per patient for the third quarter of the current fiscal year was $68.08, an increase of 11% over the $61.60 reported for the same quarter of the prior fiscal year. The number of patients served increased 22% to 953 in the current quarter from the prior year second quarter total of 783. Esoteric business for the Company was 44% of revenues for the third quarter of the current fiscal year.
